Help - Search - Members - Calendar
Full Version: Dilated-Cardiomyopathy
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Cardiology > Dilated-Cardiomyopathy
Pages: 1, 2, 3
  1. DCM: Gene expression profiling from endomyocardial biopsy tissue allows distinction between subentities of dilated cardiomyopathy. (0 replies)
  2. DCM: Cardiac magnetic resonance imaging of myocardial contrast-uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. (0 replies)
  3. DCM: Cardiac troponin t mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. (0 replies)
  4. DCM: [case report and review about radiofrequency catheter ablation in a patient with dilated cardiomyopathy and an implantable cardioverter defibrillator.] (0 replies)
  5. DCM: A novel mutation in a large french-canadian family with lgmd1b. (0 replies)
  6. DCM: Atrial fibrillation among older adults: pathophysiology, symptoms, and treatment. (0 replies)
  7. DCM: Reduced troponin i phosphorylation and increased ca(2+)-dependent atp-consumption in triton x-skinned fiber preparations from galphaq overexpressor mice. (0 replies)
  8. DCM: Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure. (0 replies)
  9. DCM: The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy - a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic a (0 replies)
  10. DCM: Effect of pimobendan on case fatality rate in doberman pinschers with congestive heart failure caused by dilated cardiomyopathy. (0 replies)
  11. DCM: Bradycardia-associated syncope in 7 boxers with ventricular tachycardia (2002-2005). (0 replies)
  12. DCM: Doppler myocardial imaging in the diagnosis of early systolic left ventricular dysfunction in diabetic rats. (1 reply)
  13. DCM: Impact of cardiac resynchronisation therapy on adaptation of circulatory and respiratory systems to exercise assessed by cardiopulmonary exercise test in patients with chronic heart failure. (1 reply)
  14. DCM: [original contributions] differentiation of ischemic and dilated cardiomyopathy on electrocardiograms (1 reply)
  15. DCM: [original contributions] intramyocardial angiogenic cell precursor injection for cardiomyopathy (1 reply)
  16. DCM: Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy (1 reply)
  17. DCM: Nt-probnp response to dobutamine stress echocardiography predicts left ventricular contractile reserve in dilated cardiomyopathy. (1 reply)
  18. DCM: [original articles] evolution of tricuspid regurgitation after mitral valve repair for functional mitral regurgitation in dilated cardiomyopathy (1 reply)
  19. DCM: [pediatrics] substantia nigra mr imaging signal changes and cardiomyopathy following prenatal exposure to cocaine and heroin (1 reply)
  20. DCM: Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end-stage hypertrophic cardiomyopathy. (1 reply)
  21. DCM: Evaluation of mechanical dyssynchrony in children with idiopathic dilated cardiomyopathy and associated clinical outcomes. (1 reply)
  22. DCM: Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. (1 reply)
  23. DCM: Diastolic heart failure in the elderly: in-hospital and long-term outcome after the first episode. (1 reply)
  24. DCM: Myocardial tumor necrosis factor-alpha expression in a sudden death due to dilated cardiomyopathy with endomyoelastofibrosis. (1 reply)
  25. DCM: Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. (1 reply)
  26. DCM: Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (1 reply)
  27. DCM: Cardiac remodelling: concentric versus eccentric hypertrophy in strength and endurance athletes. (1 reply)
  28. DCM: Complete hematopoietic recovery after continuous iron chelation therapy in a patient with severe aplastic anemia with secondary hemochromatosis. (1 reply)
  29. DCM: Discovering novel targets for autoantibodies in dilated cardiomyopathy (1 reply)
  30. DCM: Dystrophin deficiency in drosophila reduces lifespan and causes a dilated cardiomyopathy phenotype (1 reply)
  31. DCM: Mike's only hope was a heart swop - until he walked his way off the danger list (1 reply)
  32. DCM: Coenzyme q10 and high-sensitivity c-reactive protein in ischemic and idiopathic dilated cardiomyopathy (1 reply)
  33. DCM: His-purkinje system re-entry in patients with clustering ventricular tachycardia episodes (1 reply)
  34. DCM: Activation of stat1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis. (1 reply)
  35. DCM: Antigenic stimulation in the simian model of hiv infection yields dilated cardiomyopathy through effects of tnf[alpha]. (1 reply)
  36. DCM: Deletion of ptpn11 (shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and rhoa signaling pathways. (1 reply)
  37. DCM: Resolution of pathologic q wave, left ventricular dysfunction and mitral regurgitation after dual coronary repair of the anomalous origin of the left coronary artery from the pulmonary artery (1 reply)
  38. DCM: Anticoagulants, antiplatelets, and statins in heart failure. (1 reply)
  39. DCM: Possible association of hla-drb1 gene with the autoantibody against myocardial mitochondria adp/atp carrier in dilated cardiomyopathy (1 reply)
  40. DCM: Cardiac oxidative stress is elevated at the onset of dilated cardiomyopathy in streptozotocin-diabetic rats (1 reply)
  41. DCM: Decreased small arterial compliance with increased serum vascular endothelial growth factor-a and circulating endothelial progenitor cell in dilated cardiomyopathy. (1 reply)
  42. DCM: [rf ablation of longstanding persistent atrial fibrillation in patient with familial dilated cardiomyopathy.] (0 replies)
  43. DCM: Effect of intravenous positive inotropic therapy on myocardial damage in patients with dilated cardiomyopathy. (0 replies)
  44. DCM: Association between angiotensin converting enzyme (ace) gene i/d polymorphism frequency and plasma ace concentration in patients with idiopathic dilated cardiomyopathy. (0 replies)
  45. DCM: Lipoprotein lipase-derived fatty acids: physiology and dysfunction (0 replies)
  46. DCM: Effects of mesenchymal stem cell transplantation on cardiac function, structure, and electrophysiology in rabbits with dilated cardiomyopathy (0 replies)
  47. DCM: Cardiac resynchronization therapy: "nonresponders" and "hyperresponders". (0 replies)
  48. DCM: Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy. (0 replies)
  49. DCM: Incidence, causes, and outcomes of dilated cardiomyopathy in children. (0 replies)
  50. DCM: Gap junction remodeling in human heart failure is associated with increased interaction of connexin43 with zo-1. (0 replies)
  51. DCM: Mutations in the z-band protein myopalladin gene and idiopathic dilated cardiomyopathy. (0 replies)
  52. DCM: Genetic complexity of autoimmune myocarditis. (0 replies)
  53. DCM: Vanishing multiple thrombi in left ventricle of a patient with dilated cardiomyopathy. (1 reply)
  54. DCM: Cardiac functions in children with coeliac disease during follow-up: insights from tissue doppler imaging. (1 reply)
  55. DCM: Prognostic value of pentraxin 3 in patients with chronic heart failure. (1 reply)
  56. DCM: A novel mitochondrial dna trnaile (m.4322dupc) mutation associated with idiopathic dilated cardiomyopathy. (1 reply)
  57. DCM: [original articles] selected ventriculoplasty for idiopathic dilated cardiomyopathy with advanced congestive heart failure: midterm results and risk analysis (1 reply)
  58. DCM: Myosin transducer mutations differentially affect motor function, myofibril structure, and the performance of skeletal and cardiac muscles. (1 reply)
  59. DCM: [molecular biological virus identification in dilated cardiomyopathy.] (1 reply)
  60. DCM: Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy (1 reply)
  61. DCM: Interaction of bmp10 with tcap may modulate the course of hypertensive cardiac hypertrophy (1 reply)
  62. DCM: Inducible and myocyte-specific inhibition of pkc{alpha} enhances cardiac contractility and protects against infarction-induced heart failure (1 reply)
  63. DCM: Surgical methods to reverse left ventricular remodeling (1 reply)
  64. DCM: Canine candidate genes for dilated cardiomyopathy:
    annotation of and polymorphic markers for 14 genes     (1 reply)
  65. DCM: Mitral valve repair for dilated cardiomyopathy: predictive role of right ventricular dysfunction (1 reply)
  66. DCM: Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy? (1 reply)
  67. DCM: Heart transplantation in children: clinical outcomes in a single center. (1 reply)
  68. DCM: Efficacy of the edge-to-edge repair in the setting of a dilated ventricle: an in vitro study. (1 reply)
  69. DCM: [original articles: cardiovascular] efficacy of the edge-to-edge repair in the setting of a dilated ventricle: an in vitro study (1 reply)
  70. DCM: [original articles: cardiovascular] heart transplantation in children: clinical outcomes in a single center (1 reply)
  71. DCM: Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy. (1 reply)
  72. DCM: "z"eroing in on the role of cypher in striated muscle function, signaling, and human disease. (1 reply)
  73. DCM: [cardiac resynchronisation therapy as a cause of the electrical storm.] (1 reply)
  74. DCM: Biventricular pacing and defibrillator use in chronic heart failure. (1 reply)
  75. DCM: Loss of mxin{alpha}, an intercalated disk protein, results in cardiac hypertrophy and cardiomyopathy with conduction defects (1 reply)
  76. DCM: Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and h9c2 cell survival and aconitase activity with heat shock protein 27 (1 reply)
  77. DCM: Incomplete nonsense-mediated decay of mutant lamin a/c mrna provokes dilated cardiomyopathy and ventricular tachycardia (1 reply)
  78. DCM: Dilated cardiomyopathy induced by anti-tumor necrosis factor. (1 reply)
  79. DCM: Cardiac {beta}-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies (1 reply)
  80. DCM: Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study (1 reply)
  81. DCM: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (1 reply)
  82. DCM: [reviews] cardiac magnetic resonance in myocardial disease (1 reply)
  83. DCM: Inflammatory markers in stable heart failure and their relationship with functional class. (1 reply)
  84. DCM: Epirubicin: parvovirus infection associated with dilated cardiomyopathy in children: 2 case reports. (1 reply)
  85. DCM: Epirubicin: parvovirus infection associated with dilated cardiomyopathy in children: 2 case reports (1 reply)
  86. DCM: Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the villa pini d'abruzzo trimetazidine trial. (1 reply)
  87. DCM: [evidence-based laboratory medicine and test utilization] renal dysfunction is a confounder for plasma natriuretic peptides in detecting heart dysfunction in uremic and idiopathic dilated cardiomyopathies (1 reply)
  88. DCM: Case report cardiac resynchronisation therapy as a cause of the electrical storm (1 reply)
  89. DCM: Prognostic value of 123i-metaiodobenzylguanidine in patients with various heart diseases (1 reply)
  90. DCM: Mutations in the cardiac troponin c gene are a cause of idiopathic dilated cardiomyopathy in childhood (1 reply)
  91. DCM: Immunoadsorption in dilated cardiomyopathy. (1 reply)
  92. DCM: Alcohol use and congestive heart failure: incidence, importance, and approaches to improved history taking (1 reply)
  93. DCM: [molecular basis of cell and developmental biology] the pro-angiogenic cytokine pleiotrophin potentiates cardiomyocyte apoptosis through inhibition of endogenous akt/pkb activity (1 reply)
  94. DCM: High yield of lmna mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. (1 reply)
  95. DCM: Which skeletal myoblasts and how to be transplanted for cardiac repair? (1 reply)
  96. DCM: Increases in circulating t lymphocytes expressing hla-dr and cd40 ligand in patients with dilated cardiomyophthy (1 reply)
  97. DCM: Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy. (1 reply)
  98. DCM: Different ventricular remodelling and autonomic modulation after long-term beta-blocker treatment in hypertensive, ischaemic and idiopathic dilated cardiomyopathy. (1 reply)
  99. DCM: [global burden of cardiovascular disease] contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-saharan africa (1 reply)
  100. DCM: Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy (1 reply)
  101. DCM: Infantile cardiomyopathy caused by the t14709c mutation in the mitochondrial trna glutamic acid gene (1 reply)
  102. DCM: Clinical evaluation of the corcap cardiac support device in patients with dilated cardiomyopathy. (1 reply)
  103. DCM: Danon disease presenting with dilated cardiomyopathy and a complex phenotype (1 reply)
  104. DCM: [original articles: cardiovascular] clinical evaluation of the corcap cardiac support device in patients with dilated cardiomyopathy (1 reply)
  105. DCM: A therapeutic anti-cd4 monoclonal antibody inhibits t cell receptor signal transduction in mouse autoimmune cardiomyopathy. (1 reply)
  106. DCM: A surviving case of mitochondrial cardiomyopathy diagnosed from the symptoms of multiple organ dysfunction syndrome. (1 reply)
  107. DCM: Two cases of dilated cardiomyopathy with right ventricular wall degeneration demonstrated by late gadolinium enhanced mri. (1 reply)
  108. DCM: The panacea for cardiovascular diseases: the role of statins in the management of heart failure. (1 reply)
  109. DCM: Amiodarone-induced epididymitis: a case report and review of the literature. (1 reply)
  110. DCM: Micad and genereviews added new content (1 reply)
  111. DCM: Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects (1 reply)
  112. DCM: Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy. (1 reply)
  113. DCM: Giant-cell myocarditis in a patient presenting with dilated cardiomyopathy and ventricular tachycardias treated by immunosuppression: a case report. (1 reply)
  114. DCM: Large pericardial effusion due to peritoneopericardial fistula. (1 reply)
  115. DCM: Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation. (1 reply)
  116. DCM: [original articles] heart transplantation in patients with extreme right ventricular failure (1 reply)
  117. DCM: Repercussion of functional mitral regurgitation on reverse remodelling in cardiac resynchronization therapy (1 reply)
  118. DCM: Association between toll-like receptor 8 expression and adverse clinical outcomes in patients with enterovirus-associated dilated cardiomyopathy. (1 reply)
  119. DCM: Evaluation of tafazzin as candidate for dilated cardiomyopathy in irish wolfhounds (1 reply)
  120. DCM: [glycobiology and extracellular matrices] transforming growth factor beta1-regulated xylosyltransferase i activity in human cardiac fibroblasts and its impact for myocardial remodeling (1 reply)
  121. DCM: Fibromuscular dysplasia in association with intrauterine cocaine exposure. (1 reply)
  122. DCM: Evidence for decreased circulating apelin beyond heart involvement in uremic cardiomyopathy. (1 reply)
  123. DCM: Dysfunction of dysferlin-deficient hearts (1 reply)
  124. DCM: Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in icd-recipients-a pilot study. (1 reply)
  125. DCM: Acute metabolic decompensation and sudden death in barth syndrome: report of a family and a literature review (1 reply)
  126. DCM: Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis (1 reply)
  127. DCM: Carvedilol does not improve outcomes for children and adolescents with heart failure? (1 reply)
  128. DCM: [cardiopulmonary support and physiology] left ventricular pacing site and timing optimization during biventricular pacing using a multielectrode patch in pigs (1 reply)
  129. DCM: The efficacy of mitral valve surgery in children with dilated cardiomyopathy and severe mitral regurgitation (1 reply)
  130. DCM: 14 bp deletion polymorphism in the hla-g gene is a risk factor for idiopathic dilated cardiomyopathy in a chinese han population (1 reply)
  131. DCM: Systemic peripheral vascular resistance as a determinant of functional cardiac reserve in response to exercise in patients with heart disease (1 reply)
  132. DCM: Expanding spectrum of human ryr2-related disease. new electrocardiographic, structural, and genetic features. (1 reply)
  133. DCM: Prediction of cardiac events in patients with dilated cardiomyopathy using 123i-bmipp and 201tl myocardial scintigraphy (1 reply)
  134. DCM: Statin therapy is associated with a survival benefit in patients with non-ischaemic dilated cardiomyopathy,. (1 reply)
  135. DCM: Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse {alpha}-cardiac myosin in the laser trap assay (1 reply)
  136. DCM: Pheochromocytoma underlying hypertension, stroke, and dilated cardiomyopathy. (1 reply)
  137. DCM: Two donor hearts beat in one chest. (1 reply)
  138. DCM: Parvovirus b19 infection associated with dilated cardiomyopathy in patients with previous anthracycline exposure (1 reply)
  139. DCM: Locally produced survival cytokines il-15 and il-7 may be associated to the predominance of cd8+ t cells at heart lesions of human chronic chagas disease cardiomyopathy (1 reply)
  140. DCM: Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy (1 reply)
  141. DCM: [molecular basis of cell and developmental biology] replacement of nonmuscle myosin ii-b with ii-a rescues brain but not cardiac defects in mice (1 reply)
  142. DCM: [beta]1- and [beta]2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy. (1 reply)
  143. DCM: Cell infiltration caused deterioration in the prognosis of patients with clinical diagnosis of dilated cardiomyopathy (dcm): application of biopsy criteria of myocarditis to 42 autopsy cases (1 reply)
  144. DCM: [left coronary artery embolism resulting from ineffective anticoagulation in a patient suffering from dilated cardiomyopathy as a possible cause of myocardial infarction - a case report.] (1 reply)
  145. DCM: Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy. (1 reply)
  146. DCM: Recessive dystrophic epidermolysis bullosa associated with dilated cardiomyopathy (1 reply)
  147. DCM: Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure (1 reply)
  148. DCM: Nonsyndromic hearing loss dfna10 and a novel mutation of eya4: evidence for correlation of normal cardiac phenotype with truncating mutations of the eya domain (1 reply)
  149. DCM: [original research] effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy (1 reply)
  150. DCM: [original research] thr164ile polymorphism of {beta}2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy (1 reply)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2008 Invision Power Services, Inc.